nodes	percent_of_prediction	percent_of_DWPC	metapath
Colistimethate—Nephropathy toxic—Mitoxantrone—sarcoma	0.0235	0.0235	CcSEcCtD
Colistimethate—Respiratory distress—Vincristine—sarcoma	0.0218	0.0218	CcSEcCtD
Colistimethate—Nephropathy toxic—Etoposide—sarcoma	0.0195	0.0195	CcSEcCtD
Colistimethate—Oliguria—Thiotepa—sarcoma	0.0169	0.0169	CcSEcCtD
Colistimethate—Drug hypersensitivity—Epirubicin—sarcoma	0.0156	0.0156	CcSEcCtD
Colistimethate—Proteinuria—Mitoxantrone—sarcoma	0.0153	0.0153	CcSEcCtD
Colistimethate—Protein urine present—Mitoxantrone—sarcoma	0.0151	0.0151	CcSEcCtD
Colistimethate—Blood urea increased—Thiotepa—sarcoma	0.0147	0.0147	CcSEcCtD
Colistimethate—Drug hypersensitivity—Doxorubicin—sarcoma	0.0144	0.0144	CcSEcCtD
Colistimethate—Apnoea—Etoposide—sarcoma	0.0132	0.0132	CcSEcCtD
Colistimethate—Blood urea increased—Mitoxantrone—sarcoma	0.0127	0.0127	CcSEcCtD
Colistimethate—Chest discomfort—Etoposide—sarcoma	0.0127	0.0127	CcSEcCtD
Colistimethate—Candida infection—Etoposide—sarcoma	0.0107	0.0107	CcSEcCtD
Colistimethate—Blood creatinine increased—Thiotepa—sarcoma	0.0106	0.0106	CcSEcCtD
Colistimethate—Blood creatinine increased—Mitoxantrone—sarcoma	0.00916	0.00916	CcSEcCtD
Colistimethate—Haemoptysis—Epirubicin—sarcoma	0.00848	0.00848	CcSEcCtD
Colistimethate—Epistaxis—Thiotepa—sarcoma	0.00823	0.00823	CcSEcCtD
Colistimethate—Haemoptysis—Doxorubicin—sarcoma	0.00785	0.00785	CcSEcCtD
Colistimethate—Urinary tract disorder—Thiotepa—sarcoma	0.00773	0.00773	CcSEcCtD
Colistimethate—Connective tissue disorder—Thiotepa—sarcoma	0.0077	0.0077	CcSEcCtD
Colistimethate—Urethral disorder—Thiotepa—sarcoma	0.00768	0.00768	CcSEcCtD
Colistimethate—Dysphonia—Epirubicin—sarcoma	0.00763	0.00763	CcSEcCtD
Colistimethate—Tinnitus—Thiotepa—sarcoma	0.0073	0.0073	CcSEcCtD
Colistimethate—Immune system disorder—Thiotepa—sarcoma	0.00707	0.00707	CcSEcCtD
Colistimethate—Dysphonia—Doxorubicin—sarcoma	0.00706	0.00706	CcSEcCtD
Colistimethate—Mediastinal disorder—Thiotepa—sarcoma	0.00706	0.00706	CcSEcCtD
Colistimethate—Bronchospasm—Etoposide—sarcoma	0.00691	0.00691	CcSEcCtD
Colistimethate—Mental disorder—Thiotepa—sarcoma	0.00686	0.00686	CcSEcCtD
Colistimethate—Urinary tract disorder—Vincristine—sarcoma	0.00686	0.00686	CcSEcCtD
Colistimethate—Connective tissue disorder—Vincristine—sarcoma	0.00682	0.00682	CcSEcCtD
Colistimethate—Malnutrition—Thiotepa—sarcoma	0.00682	0.00682	CcSEcCtD
Colistimethate—Oliguria—Epirubicin—sarcoma	0.00681	0.00681	CcSEcCtD
Colistimethate—Urethral disorder—Vincristine—sarcoma	0.00681	0.00681	CcSEcCtD
Colistimethate—Dysarthria—Epirubicin—sarcoma	0.00664	0.00664	CcSEcCtD
Colistimethate—Creatinine increased—Epirubicin—sarcoma	0.0066	0.0066	CcSEcCtD
Colistimethate—Oliguria—Doxorubicin—sarcoma	0.00631	0.00631	CcSEcCtD
Colistimethate—Mediastinal disorder—Vincristine—sarcoma	0.00626	0.00626	CcSEcCtD
Colistimethate—Dysarthria—Doxorubicin—sarcoma	0.00614	0.00614	CcSEcCtD
Colistimethate—Creatinine increased—Doxorubicin—sarcoma	0.0061	0.0061	CcSEcCtD
Colistimethate—Salivary hypersecretion—Epirubicin—sarcoma	0.0061	0.0061	CcSEcCtD
Colistimethate—Mental disorder—Vincristine—sarcoma	0.00608	0.00608	CcSEcCtD
Colistimethate—Candida infection—Epirubicin—sarcoma	0.006	0.006	CcSEcCtD
Colistimethate—Cough—Thiotepa—sarcoma	0.00595	0.00595	CcSEcCtD
Colistimethate—Blood urea increased—Epirubicin—sarcoma	0.00593	0.00593	CcSEcCtD
Colistimethate—Convulsion—Thiotepa—sarcoma	0.00591	0.00591	CcSEcCtD
Colistimethate—Arthralgia—Thiotepa—sarcoma	0.0058	0.0058	CcSEcCtD
Colistimethate—Anxiety—Thiotepa—sarcoma	0.00578	0.00578	CcSEcCtD
Colistimethate—Dysgeusia—Mitoxantrone—sarcoma	0.00577	0.00577	CcSEcCtD
Colistimethate—Salivary hypersecretion—Doxorubicin—sarcoma	0.00564	0.00564	CcSEcCtD
Colistimethate—Urinary tract disorder—Etoposide—sarcoma	0.00556	0.00556	CcSEcCtD
Colistimethate—Candida infection—Doxorubicin—sarcoma	0.00555	0.00555	CcSEcCtD
Colistimethate—Urethral disorder—Etoposide—sarcoma	0.00552	0.00552	CcSEcCtD
Colistimethate—Blood urea increased—Doxorubicin—sarcoma	0.00549	0.00549	CcSEcCtD
Colistimethate—Nervous system disorder—Thiotepa—sarcoma	0.00546	0.00546	CcSEcCtD
Colistimethate—Vertigo—Vincristine—sarcoma	0.00543	0.00543	CcSEcCtD
Colistimethate—Convulsion—Vincristine—sarcoma	0.00524	0.00524	CcSEcCtD
Colistimethate—Cough—Mitoxantrone—sarcoma	0.00514	0.00514	CcSEcCtD
Colistimethate—Convulsion—Mitoxantrone—sarcoma	0.0051	0.0051	CcSEcCtD
Colistimethate—Immune system disorder—Etoposide—sarcoma	0.00508	0.00508	CcSEcCtD
Colistimethate—Mediastinal disorder—Etoposide—sarcoma	0.00507	0.00507	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00507	0.00507	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00503	0.00503	CcSEcCtD
Colistimethate—Arthralgia—Mitoxantrone—sarcoma	0.00501	0.00501	CcSEcCtD
Colistimethate—Chest pain—Mitoxantrone—sarcoma	0.00501	0.00501	CcSEcCtD
Colistimethate—Paraesthesia—Thiotepa—sarcoma	0.005	0.005	CcSEcCtD
Colistimethate—Anxiety—Mitoxantrone—sarcoma	0.005	0.005	CcSEcCtD
Colistimethate—Somnolence—Thiotepa—sarcoma	0.00495	0.00495	CcSEcCtD
Colistimethate—Nervous system disorder—Vincristine—sarcoma	0.00484	0.00484	CcSEcCtD
Colistimethate—Decreased appetite—Thiotepa—sarcoma	0.00484	0.00484	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Thiotepa—sarcoma	0.0048	0.0048	CcSEcCtD
Colistimethate—Decreased appetite—Dactinomycin—sarcoma	0.0048	0.0048	CcSEcCtD
Colistimethate—Fatigue—Thiotepa—sarcoma	0.0048	0.0048	CcSEcCtD
Colistimethate—Dysgeusia—Etoposide—sarcoma	0.0048	0.0048	CcSEcCtD
Colistimethate—Fatigue—Dactinomycin—sarcoma	0.00476	0.00476	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Vincristine—sarcoma	0.0045	0.0045	CcSEcCtD
Colistimethate—Paraesthesia—Vincristine—sarcoma	0.00443	0.00443	CcSEcCtD
Colistimethate—Urticaria—Thiotepa—sarcoma	0.00442	0.00442	CcSEcCtD
Colistimethate—Vertigo—Etoposide—sarcoma	0.0044	0.0044	CcSEcCtD
Colistimethate—Body temperature increased—Thiotepa—sarcoma	0.0044	0.0044	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00438	0.00438	CcSEcCtD
Colistimethate—Body temperature increased—Dactinomycin—sarcoma	0.00437	0.00437	CcSEcCtD
Colistimethate—Paraesthesia—Mitoxantrone—sarcoma	0.00431	0.00431	CcSEcCtD
Colistimethate—Decreased appetite—Vincristine—sarcoma	0.00429	0.00429	CcSEcCtD
Colistimethate—Dyspnoea—Mitoxantrone—sarcoma	0.00428	0.00428	CcSEcCtD
Colistimethate—Cough—Etoposide—sarcoma	0.00427	0.00427	CcSEcCtD
Colistimethate—Somnolence—Mitoxantrone—sarcoma	0.00427	0.00427	CcSEcCtD
Colistimethate—Blood creatinine increased—Epirubicin—sarcoma	0.00427	0.00427	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Vincristine—sarcoma	0.00426	0.00426	CcSEcCtD
Colistimethate—Fatigue—Vincristine—sarcoma	0.00425	0.00425	CcSEcCtD
Colistimethate—Convulsion—Etoposide—sarcoma	0.00424	0.00424	CcSEcCtD
Colistimethate—Decreased appetite—Mitoxantrone—sarcoma	0.00418	0.00418	CcSEcCtD
Colistimethate—Chest pain—Etoposide—sarcoma	0.00417	0.00417	CcSEcCtD
Colistimethate—Fatigue—Mitoxantrone—sarcoma	0.00414	0.00414	CcSEcCtD
Colistimethate—Hypersensitivity—Thiotepa—sarcoma	0.0041	0.0041	CcSEcCtD
Colistimethate—Hypersensitivity—Dactinomycin—sarcoma	0.00407	0.00407	CcSEcCtD
Colistimethate—Asthenia—Thiotepa—sarcoma	0.00399	0.00399	CcSEcCtD
Colistimethate—Asthenia—Dactinomycin—sarcoma	0.00396	0.00396	CcSEcCtD
Colistimethate—Blood creatinine increased—Doxorubicin—sarcoma	0.00395	0.00395	CcSEcCtD
Colistimethate—Asthma—Epirubicin—sarcoma	0.00394	0.00394	CcSEcCtD
Colistimethate—Body temperature increased—Vincristine—sarcoma	0.0039	0.0039	CcSEcCtD
Colistimethate—Urticaria—Mitoxantrone—sarcoma	0.00382	0.00382	CcSEcCtD
Colistimethate—Diarrhoea—Thiotepa—sarcoma	0.00381	0.00381	CcSEcCtD
Colistimethate—Body temperature increased—Mitoxantrone—sarcoma	0.0038	0.0038	CcSEcCtD
Colistimethate—Diarrhoea—Dactinomycin—sarcoma	0.00378	0.00378	CcSEcCtD
Colistimethate—Dizziness—Thiotepa—sarcoma	0.00368	0.00368	CcSEcCtD
Colistimethate—Asthma—Doxorubicin—sarcoma	0.00365	0.00365	CcSEcCtD
Colistimethate—Hypersensitivity—Vincristine—sarcoma	0.00364	0.00364	CcSEcCtD
Colistimethate—Paraesthesia—Etoposide—sarcoma	0.00359	0.00359	CcSEcCtD
Colistimethate—Dyspnoea—Etoposide—sarcoma	0.00356	0.00356	CcSEcCtD
Colistimethate—Somnolence—Etoposide—sarcoma	0.00355	0.00355	CcSEcCtD
Colistimethate—Hypersensitivity—Mitoxantrone—sarcoma	0.00354	0.00354	CcSEcCtD
Colistimethate—Asthenia—Vincristine—sarcoma	0.00354	0.00354	CcSEcCtD
Colistimethate—Vomiting—Thiotepa—sarcoma	0.00354	0.00354	CcSEcCtD
Colistimethate—Vomiting—Dactinomycin—sarcoma	0.00351	0.00351	CcSEcCtD
Colistimethate—Rash—Thiotepa—sarcoma	0.00351	0.00351	CcSEcCtD
Colistimethate—Dermatitis—Thiotepa—sarcoma	0.00351	0.00351	CcSEcCtD
Colistimethate—Headache—Thiotepa—sarcoma	0.00349	0.00349	CcSEcCtD
Colistimethate—Rash—Dactinomycin—sarcoma	0.00348	0.00348	CcSEcCtD
Colistimethate—Decreased appetite—Etoposide—sarcoma	0.00347	0.00347	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Etoposide—sarcoma	0.00345	0.00345	CcSEcCtD
Colistimethate—Asthenia—Mitoxantrone—sarcoma	0.00345	0.00345	CcSEcCtD
Colistimethate—Fatigue—Etoposide—sarcoma	0.00345	0.00345	CcSEcCtD
Colistimethate—Diarrhoea—Vincristine—sarcoma	0.00338	0.00338	CcSEcCtD
Colistimethate—Epistaxis—Epirubicin—sarcoma	0.00331	0.00331	CcSEcCtD
Colistimethate—Nausea—Thiotepa—sarcoma	0.00331	0.00331	CcSEcCtD
Colistimethate—Diarrhoea—Mitoxantrone—sarcoma	0.00329	0.00329	CcSEcCtD
Colistimethate—Nausea—Dactinomycin—sarcoma	0.00328	0.00328	CcSEcCtD
Colistimethate—Dizziness—Vincristine—sarcoma	0.00326	0.00326	CcSEcCtD
Colistimethate—Urticaria—Etoposide—sarcoma	0.00318	0.00318	CcSEcCtD
Colistimethate—Body temperature increased—Etoposide—sarcoma	0.00316	0.00316	CcSEcCtD
Colistimethate—Vomiting—Vincristine—sarcoma	0.00314	0.00314	CcSEcCtD
Colistimethate—Urinary tract disorder—Epirubicin—sarcoma	0.00311	0.00311	CcSEcCtD
Colistimethate—Rash—Vincristine—sarcoma	0.00311	0.00311	CcSEcCtD
Colistimethate—Dermatitis—Vincristine—sarcoma	0.00311	0.00311	CcSEcCtD
Colistimethate—Connective tissue disorder—Epirubicin—sarcoma	0.0031	0.0031	CcSEcCtD
Colistimethate—Urethral disorder—Epirubicin—sarcoma	0.00309	0.00309	CcSEcCtD
Colistimethate—Headache—Vincristine—sarcoma	0.00309	0.00309	CcSEcCtD
Colistimethate—Epistaxis—Doxorubicin—sarcoma	0.00307	0.00307	CcSEcCtD
Colistimethate—Vomiting—Mitoxantrone—sarcoma	0.00306	0.00306	CcSEcCtD
Colistimethate—Rash—Mitoxantrone—sarcoma	0.00303	0.00303	CcSEcCtD
Colistimethate—Dermatitis—Mitoxantrone—sarcoma	0.00303	0.00303	CcSEcCtD
Colistimethate—Headache—Mitoxantrone—sarcoma	0.00301	0.00301	CcSEcCtD
Colistimethate—Hypersensitivity—Etoposide—sarcoma	0.00294	0.00294	CcSEcCtD
Colistimethate—Tinnitus—Epirubicin—sarcoma	0.00294	0.00294	CcSEcCtD
Colistimethate—Nausea—Vincristine—sarcoma	0.00293	0.00293	CcSEcCtD
Colistimethate—Urinary tract disorder—Doxorubicin—sarcoma	0.00288	0.00288	CcSEcCtD
Colistimethate—Asthenia—Etoposide—sarcoma	0.00287	0.00287	CcSEcCtD
Colistimethate—Connective tissue disorder—Doxorubicin—sarcoma	0.00287	0.00287	CcSEcCtD
Colistimethate—Urethral disorder—Doxorubicin—sarcoma	0.00286	0.00286	CcSEcCtD
Colistimethate—Nausea—Mitoxantrone—sarcoma	0.00285	0.00285	CcSEcCtD
Colistimethate—Immune system disorder—Epirubicin—sarcoma	0.00285	0.00285	CcSEcCtD
Colistimethate—Mediastinal disorder—Epirubicin—sarcoma	0.00284	0.00284	CcSEcCtD
Colistimethate—Mental disorder—Epirubicin—sarcoma	0.00276	0.00276	CcSEcCtD
Colistimethate—Malnutrition—Epirubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Colistimethate—Diarrhoea—Etoposide—sarcoma	0.00273	0.00273	CcSEcCtD
Colistimethate—Tinnitus—Doxorubicin—sarcoma	0.00272	0.00272	CcSEcCtD
Colistimethate—Flatulence—Epirubicin—sarcoma	0.00271	0.00271	CcSEcCtD
Colistimethate—Dysgeusia—Epirubicin—sarcoma	0.00269	0.00269	CcSEcCtD
Colistimethate—Dizziness—Etoposide—sarcoma	0.00264	0.00264	CcSEcCtD
Colistimethate—Immune system disorder—Doxorubicin—sarcoma	0.00264	0.00264	CcSEcCtD
Colistimethate—Mediastinal disorder—Doxorubicin—sarcoma	0.00263	0.00263	CcSEcCtD
Colistimethate—Mental disorder—Doxorubicin—sarcoma	0.00256	0.00256	CcSEcCtD
Colistimethate—Vomiting—Etoposide—sarcoma	0.00254	0.00254	CcSEcCtD
Colistimethate—Malnutrition—Doxorubicin—sarcoma	0.00254	0.00254	CcSEcCtD
Colistimethate—Rash—Etoposide—sarcoma	0.00252	0.00252	CcSEcCtD
Colistimethate—Dermatitis—Etoposide—sarcoma	0.00252	0.00252	CcSEcCtD
Colistimethate—Headache—Etoposide—sarcoma	0.0025	0.0025	CcSEcCtD
Colistimethate—Flatulence—Doxorubicin—sarcoma	0.0025	0.0025	CcSEcCtD
Colistimethate—Dysgeusia—Doxorubicin—sarcoma	0.00249	0.00249	CcSEcCtD
Colistimethate—Vertigo—Epirubicin—sarcoma	0.00247	0.00247	CcSEcCtD
Colistimethate—Cough—Epirubicin—sarcoma	0.0024	0.0024	CcSEcCtD
Colistimethate—Convulsion—Epirubicin—sarcoma	0.00238	0.00238	CcSEcCtD
Colistimethate—Nausea—Etoposide—sarcoma	0.00237	0.00237	CcSEcCtD
Colistimethate—Arthralgia—Epirubicin—sarcoma	0.00234	0.00234	CcSEcCtD
Colistimethate—Chest pain—Epirubicin—sarcoma	0.00234	0.00234	CcSEcCtD
Colistimethate—Anxiety—Epirubicin—sarcoma	0.00233	0.00233	CcSEcCtD
Colistimethate—Vertigo—Doxorubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Colistimethate—Cough—Doxorubicin—sarcoma	0.00222	0.00222	CcSEcCtD
Colistimethate—Convulsion—Doxorubicin—sarcoma	0.0022	0.0022	CcSEcCtD
Colistimethate—Nervous system disorder—Epirubicin—sarcoma	0.0022	0.0022	CcSEcCtD
Colistimethate—Arthralgia—Doxorubicin—sarcoma	0.00216	0.00216	CcSEcCtD
Colistimethate—Chest pain—Doxorubicin—sarcoma	0.00216	0.00216	CcSEcCtD
Colistimethate—Anxiety—Doxorubicin—sarcoma	0.00216	0.00216	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00204	0.00204	CcSEcCtD
Colistimethate—Nervous system disorder—Doxorubicin—sarcoma	0.00203	0.00203	CcSEcCtD
Colistimethate—Paraesthesia—Epirubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Colistimethate—Dyspnoea—Epirubicin—sarcoma	0.002	0.002	CcSEcCtD
Colistimethate—Somnolence—Epirubicin—sarcoma	0.00199	0.00199	CcSEcCtD
Colistimethate—Decreased appetite—Epirubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Epirubicin—sarcoma	0.00193	0.00193	CcSEcCtD
Colistimethate—Fatigue—Epirubicin—sarcoma	0.00193	0.00193	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Colistimethate—Paraesthesia—Doxorubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Colistimethate—Dyspnoea—Doxorubicin—sarcoma	0.00185	0.00185	CcSEcCtD
Colistimethate—Somnolence—Doxorubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Colistimethate—Decreased appetite—Doxorubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00179	0.00179	CcSEcCtD
Colistimethate—Fatigue—Doxorubicin—sarcoma	0.00179	0.00179	CcSEcCtD
Colistimethate—Urticaria—Epirubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Colistimethate—Body temperature increased—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Colistimethate—Hypersensitivity—Epirubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Colistimethate—Urticaria—Doxorubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Colistimethate—Body temperature increased—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Colistimethate—Asthenia—Epirubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Colistimethate—Diarrhoea—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Colistimethate—Hypersensitivity—Doxorubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Colistimethate—Asthenia—Doxorubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Colistimethate—Dizziness—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Colistimethate—Vomiting—Epirubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Colistimethate—Diarrhoea—Doxorubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Colistimethate—Rash—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Colistimethate—Dermatitis—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Colistimethate—Headache—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Colistimethate—Dizziness—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Colistimethate—Nausea—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Colistimethate—Vomiting—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Colistimethate—Rash—Doxorubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Colistimethate—Dermatitis—Doxorubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Colistimethate—Headache—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Colistimethate—Nausea—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
